47 results
Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous
Inhibitor Use and Adherence ... EBM #Cardiology #Adherence ... #Clopidogrel #Prasugrel
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Clopidogrel to Prasugrel ... De-escalation in Potency: Prasugrel ... High Potency: Prasugrel ... Ticagrelor to Prasugrel ... antiplatelet #ticagrelor #prasugrel
Hydroxychloroquine Serum Measurement in SLE
 • Terminal elimination half-life = 40 days ([HCQI reflects long-term intake)
1500ng/mL • Non-adherence ... check therapeutic adherence ... poor therapeutic adherence
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
escalating to prasugrel ... hours after last prasugrel ... ticagrelor to prasugrel ... antiplatelet #ticagrelor #prasugrel
Escherichia coli Adherence and Pathogenic Patterns
EIEC - EPEC - ETEC - EHEC (STEC) - EAEC -
Escherichia coli Adherence ... Escherichia #Ecoli #adherence
Pathophysiology of Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar Syndrome (HHS)
Absolute Insulin deficit:
 - Type I DM:
resistance, non-adherence
Asthma GINA Guidelines 2019 
If Asthma is uncontrolled, first assess for adherence and inhaler technique -Then,
first assess for adherence ... assess patients adherence
Long-Acting Injectable (LAI) - Atypical Antipsychotics 
INVEGA TRINZA 3 MONTHS 
ARISTADA 2 MONTHS 
INVEGA 1 MONTH
SUSTENNA
Adherence to daily ... schizophrenia can make adherence
IBD - Assessment of Lack of Response (sLOR) - Differential Diagnosis
Non-inflammatory mechanisms:
 • IBS
 • Fibrostenotic
loss - Non-adherence
HIV PrEP (Pre-Exposure Prophylaxis) - Truvada 

HIV Pre-Exposure Prophylaxis (PrEP) is available in the form of
counseled for adherence ... Adherence to the